Praxis Precision Medicines, Inc.·4

May 19, 9:45 PM ET

Nemiroff Alex 4

Research Summary

AI-generated summary

Updated

Praxis (PRAX) General Counsel Alex Nemiroff Receives 78 Shares

What Happened
Alex Nemiroff, General Counsel and Secretary of Praxis Precision Medicines (PRAX), acquired 78 shares on 2026-05-14 under the company's Employee Stock Purchase Plan (ESPP). The shares were acquired at $167.94 each for a total of about $13,100. The filing reports this as an acquisition (code A), i.e., an award/benefit purchase rather than an open-market buy.

Key Details

  • Transaction date: 2026-05-14; Price: $167.94 per share; Total value: ~$13,100.
  • Transaction type/code: A (grant, award or other acquisition) via the ESPP.
  • Footnote: Shares were acquired under Praxis’s Employee Stock Purchase Plan and were exempt under Rule 16b-3(d) and Rule 16b-3(c) (i.e., compensatory plan exemption).
  • Shares owned after the transaction: not specified in the provided filing excerpt.
  • Filing date: 2026-05-19 — filed five days after the transaction (outside the typical 2-business-day Form 4 deadline).

Context: ESPP purchases are common employee compensation/benefit transactions and are often routine. The Rule 16b-3 exemption noted means this was treated as a compensatory-plan transaction exempt from certain short-swing profit recapture rules under Section 16. This filing reports an acquisition, which is generally considered more informative than routine sales, but the filing provides no explanation of intent.